|Ultima descărcare din IBN:|
| SM ISO690:2012|
UNGUREAN, Andrei; LESNIK, Evelina; MALIK, Alina; EL ABIAT, Gamil Ali; OSIPOV, Tatiana; KULCITKAIA, Stela. . In: Cercetarea în biomedicină și sănătate: calitate, excelență și performanță. (R), 20-22 octombrie 2021, Chişinău. Chișinău, Republica Moldova: 2021, p. 179. ISBN 978-9975-82-223-7 (PDF)..
|Cercetarea în biomedicină și sănătate: calitate, excelență și performanță
Conferința "Cercetarea în biomedicină și sănătate: calitate, excelență și performanță" |
1, Chişinău, Moldova, 20-22 octombrie 2021
Background. The evolution of the COVID-19 patients is characterized by the poliorganic involvement in 5% of the patients and with mild evolution in more than 2/3 affected patients. Objective of the study. The evaluation of the clinical features and the treatment outcome of the COVID-19 patients hospitalised in the Municipal Hospital of Phthisiopneumology, Chisinau, Republic of Moldova during March-April 2021 Material and Methods. It was performed an analytical, prospective and longitudinal study, which included 145 patients with COVID-19 admitted at the Municipal Clinical Hospital of Phthisiopneumology (SCMF) from Chisinau, Republic of Moldova. Results. The distribution according to the sex identified the predominance of men 108(75%) vs 37(25%) women. The average age was 68±14 y.o. Returned from abroad in the last 2 weeks were 2(1%) cases, both from EU. The common symptoms such as fever was found in 127(87%) cases, productive cough in 113(78%), dyspnea in 86(59%). The average duration of the hospitalization was 8 days. Were discharged being assessed as cured 135 (93%) patients, 3 (2%) died and were continuing the treatment in the Intensive Care Unit 7 (5%) cases. Conclusion. The peculiarities of patients with COVID-19 hospitalized in the clinical subdivisions of SCMFP were male sex, average age over 68 years, contracting the infection in the country, fever and productive cough, dyspnea in every second, with the healing of most of patients.
COVID-19, clinical signs, Outcome,
COVID-19, semne clinice, rezultat therapeutic